(Q43299685)

English

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.

scientific article published in September 2009

In more languages
default for all languages
No label defined

No description defined

Statements

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit